Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Head & Neck|November 19, 2025
Geriatric Nutritional Risk Index Predicts Treatment Intolerance and Survival in Head and Neck CancerRaisa Chowdhury, Alex M Mlynarek, Keith Richardson, et al.
Head & Neck|August 13, 2025
Fuel for Recovery: Predicting G-Tube Dependence in HPV-Negative Operable HNSCCMarie-Michelle McNicoll, Alex M Mlynarek, Keith Richardson, et al.
Oncotargets and Therapy|October 2, 2018
Evaluation of supportive and barrier-protective skin care products in the daily prevention and treatment of cutaneous toxicity during systemic chemotherapyDiana Lüftner, Veronica Dell'Acqua, Frédéric Selle, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2011
Stereotactic fractionated radiotherapy in the treatment of juxtapapillary choroidal melanoma: the McGill University experienceRolina Al-Wassia, Alan Dal Pra, Kitty Shun, et al.
Head & Neck|June 10, 2025
Sarcopenia Trajectories Predict Survival in Operable Head and Neck CancerMarco A Mascarella, Alex Mlynarek, Keith Richardson, et al.
Head & Neck|June 10, 2025
Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) Predicts Treatment Toxicity and Intolerance in Operable Head and Neck Cancer: An Ambispective Cohort StudyRaisa Chowdhury, Karim Botros, Keith Richardson, et al.
Head & Neck|February 14, 2024
Sarcopenia predicts short-term treatment-related toxicity in patients undergoing curative-intent therapy for head and neck cancer: A systematic review and meta-analysisMarco A Mascarella, Jannatul Ferdus, Varun Vendra, et al.
Journal of Geriatric Oncology|September 13, 2024
Predicting short-term treatment toxicity in head and neck cancer through a systematic review and meta-analysisMarco A Mascarella, Varun Vendra, Khalil Sultanem, et al.
Head & Neck|August 23, 2019
Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology StudyRonald C Eldridge, Stephanie L Pugh, Andy Trotti, et al.
International Journal of Radiation Oncology, Biology, Physics|February 12, 2015
Long-term results of radiation therapy oncology group 9903: a randomized phase 3 trial to assess the effect of erythropoietin on local-regional control in anemic patients treated with radiation therapy for squamous cell carcinoma of the head and neckGeorge Shenouda, Qiang Zhang, K Kian Ang, et al.
Pageof 8